International (NL-UK) double-blind study of Sinemet CR and standard Sinemet (25/100) in 170 patients with fluctuating Parkinson's disease

Journal of Neurology

Volumn 243, Issue 3, 1996, Pages 235-240

  Wolters, Erik C ^a   Tesselaar, H J Marleen ^b   Bussemaker, F E A M ^c   Dammers, J W H H ^c   Haas, J A ^c   Horstink, M W I M ^c   Jansen, E N H ^c   Korten, J J ^c   Lakke, J P W F ^c   Op De Coul, A A W ^c   Peperkamp, J P C ^c   Roos, R A C ^c   Rutgers, A W F ^c   Tijssen, C C ^c   Van Der Zwan, A ^c   Van Laar, T ^c   Van Leusden, J A ^c   Van Rossum, J ^c   Verbiest, H B C ^c   Vermeij, A J ^c   Wolters, E C ^c   Bakheit, J ^c   Bates, D ^c   Capildeo, R ^c   Chand, J ^c   Kennedy, P ^c   Lees, A ^c   Park, D ^c   Sturman, S ^c   Turjanski, N ^c   WilliamsA , ^c   more..

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b NV ORGANON   (Netherlands)

^c NONE

Author keywords

Motor fluctuations; Parkinson's disease; Sinemet CR

Indexed keywords

CARBIDOPA PLUS LEVODOPA; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG DOSE; DRUG EFFICACY; DRUG THERAPY; DYSKINESIA; DYSTONIA; HALLUCINATION; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SLEEP; SUSTAINED RELEASE PREPARATION; VOMITING;

ADULT; AGED; ANTIPARKINSON AGENTS; CARBIDOPA; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; HUMANS; INTERNATIONAL COOPERATION; LEVODOPA; MIDDLE AGED; PARKINSON DISEASE;

EID: 0012313066     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00868520     Document Type: Article

References (19)

1. Bush DF, Liss CL, Morton A, Sinemet CR Multicenter Study Group (1989) An open multicenter long-term treatment evaluation of Sinemet CR. Neurology 39 [Suppl 2]:101-104
2. Deleu D, Jacques M, Michotte Y, Ebinger G (1989) Controlled-release carbidopa/levodopa (CR) in Parkinsonian patients with response fluctuations on standard levodopa treatment: clinical and pharmacokinetic observations. Neurology 39 [Suppl 2]:88-92
3. Fahn S (1974) "On-off" phenomenon with levodopa therapy in parkinsonism. Neurology 24:431-441
4. Feldman RG, Mosbach PA, Kelly MR, Thomas CA, Saint Hilaire MH (1989) Double-blind comparison of standard Sinemet and Sinemet CR in patients with mild-to-moderate Parkinson's disease. Neurology 39 [Suppl 2]:96-101
5. Friedman JH (1988) An open trial of continuous release carbidopa/1-dopa (Sinemet CR) for the treatment of mild to moderate Parkinson's disease. Neurology 38 [Suppl 1]:180
6. Goetz CG, Tanner CM, Klawans HL, et al (1987) Parkinson's disease and motor fluctuations: long acting carbidopa/levodopa (CR4-Sinemet). Neurology 37:837-878
7. Goetz CG, Tanner CM, Shannon KM, et al (1988) Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Neurology 38:1143-1146
8. Hardie RJ, Lees AJ, Stern GM (1984) On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study. Brain 107:487-506
9. Hutton JT, Morris JL (1991) Long-term evaluation of Sinemet CR in parkinsonian patients with motor fluctuations. Can J Neurol Sci 18:467-471
10. Hutton JT, Morris JL, Gustavo CR, et al (1988) Treatment of chronic Parkinson's disease with controlled-release carbidopa/levodopa. Neurology 45: 861-864
11. Hutton JT, Morris JL, Bush DF, Smith ME, Liss CL, Reines S (1989) Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease. Neurology 39 [Suppl 2]:67-72
12. Marsden CD, Parkes JD (1977) Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet 1: 345-349
13. McCullagh P (1980) Regression models for ordinal date. IRSS [B] 42: 109-142
14. Pfeiffer RF, Wilken KE, Glaeske C (1988) Sinemet CR4 in Parkinson's disease. Neurology 38 [Suppl 1]:419
15. Quinn N, Parkes JD, Marsden CD (1984) Control of on/off phenomenon by continuous intravenous infusion of levodopa. Neurology 34:1131-1136
16. Rondot P, Ziegler M, Aymard N, Teinturier A (1989) Effect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease. Neurology 39 [Suppl 2]: 74-77
17. Sage JI, Mark MH (1988) Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25/100) in advanced Parkinson's disease: a double-blind cross-over study. Clin Neuropharmacol 11:174-179
18. Wolters EC, Horstink MWIM, Roos RAC, Jansen ENH (1992) Superior clinical efficacy of Sinemet CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. Adv Neurol 60:648-652
19. Yeh KC, August TF, Bush DF, et al (1989) Pharmacokinetics and bioavailability of Sinemet CR: summary of human studies. Neurology 39 [Suppl 2]: 25-38